Back

A meta analysis of effects of high-intensity statin and pcsk-9 inhibitor therapies on coronary plaque burden

1 September 2025 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Multimodality imaging of coronary artery disease Imaging of Coronary Artery Disease ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Erdin Tokmak

University of Duisburg-Essen - West-German Heart and Vascular Centre, Essen (Germany)

7 More presentations in this session

Presentation thumbnail
Lipid core burden index and new LDL-C calculation in predicting non-culprit coronary events in very high-risk patients: Insights from the Lipid-Rich Plaque Study
Associate Professor J. Wykrzykowska (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Relationship between lipoprotein(a) and pancoronary plaque vulnerability in patients with acute coronary syndrome: a three-vessel optical coherence tomography study
Doctor C. Fang (Harbin, CN)
Abstract Slides Video
Presentation thumbnail
Long-term prognostic value of residual lipid burden in acute myocardial infarction: a three-vessel optical coherence tomography study
Doctor L. Cui (Harbin, CN)
Abstract Slides Video
Presentation thumbnail
Impact of modified vs. non-compliant balloons on tissue modifications in severely calcified lesions following atherectomy: a DIRO sub-study
Doctor S. Kawanami (Sakai, JP)
Abstract Slides Video
Presentation thumbnail
IVUS findings predicting the indication for intravascular lithotripsy in PCI
Doctor K. Hattori (Yokohama, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Multimodality imaging of coronary artery disease

The Event

Event poster

ESC Congress 2025

1 September 2025 09:15 CET
You may be interested in
thumbnail
Congress Presentation
PCSK9 inhibitors and coronary atherosclerotic plaque modification: a meta-analysis
thumbnail
Congress Presentation
The efficacy of dual lipid-lowering therapy with ezetimibe and statin on plaque volume regression among patients following percutaneous coronary intervention: a meta-analysis
thumbnail
Congress Presentation
Inclisiran-containing low-density lipoprotein cholesterol reduction effectively stabilizes atherosclerotic plaques

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources